Skip to main content

Day: April 16, 2025

Rogers Communications Inc. Announces Successful Completion of Consent Solicitations for Senior Notes to Facilitate Subsidiary Equity Investment

TORONTO, April 16, 2025 (GLOBE NEWSWIRE) — Rogers Communications Inc. (TSX: RCI.A and RCI.B; NYSE: RCI) (“Rogers”) today announced that, in connection with its previously announced consent solicitations, it has received the requisite consents to amend the indentures governing each of the notes listed below (the “Notes”) as reported by the tabulation agents and as contemplated by such consent solicitations. As a result, Rogers will execute amendments to the indentures governing the Notes to (i) unequivocally clarify that the subsidiary equity investment previously announced by Rogers is not subject to the covenant limiting debt of Rogers’ subsidiaries or the other negative covenants of, and is otherwise permitted by, and does not constitute a default under, the applicable indentures and (ii) with respect to the Shaw Notes...

Continue reading

Cullinan Therapeutics Receives Approval from European Medicines Agency to Initiate Phase 1 Trial of CLN-978, a Bispecific CD19 T Cell Engager Administered Subcutaneously, in Patients with Rheumatoid Arthritis

Company-sponsored clinical trial will be initiated at FAU Erlangen-Nuremberg in Germany and Università Cattolica del Sacro Cuore, Rome in Q2 2025 CLN-978 is also being studied in the U.S., Europe, and Australia for systemic lupus erythematosus CAMBRIDGE, Mass., April 16, 2025 (GLOBE NEWSWIRE) — Cullinan Therapeutics, Inc. (Nasdaq: CGEM), a biopharmaceutical company focused on developing modality-agnostic targeted therapies, today announced that the European Medicines Agency (EMA) approved the Company’s Clinical Trial Application (CTA) for CLN-978. The Phase 1 clinical trial will assess CLN-978 in patients with active, difficult-to-treat rheumatoid arthritis meeting the 2010 American College of Rheumatology (ACR)/European Alliance of Associations for Rheumatology (EULAR) Classification Criteria. This open-label study will evaluate...

Continue reading

OTC Markets Group Welcomes Sprott Physical Copper Trust to OTCQX

NEW YORK, April 16, 2025 (GLOBE NEWSWIRE) — OTC Markets Group Inc. (OTCQX: OTCM), operator of regulated markets for trading 12,000 U.S. and international securities, today announced Sprott Physical Copper Trust (TSX: COP.UN; OTCQX: SPHCF), has qualified to trade on the OTCQX® Best Market. Sprott Physical Copper Trust upgraded to OTCQX from the OTCQB® Venture Market. Sprott Physical Copper Trust begins trading today on OTCQX under the symbol “SPHCF.” U.S. investors can find current financial disclosure and Real-Time Level 2 quotes for the company on www.otcmarkets.com. The OTCQX Market is designed for established, investor-focused U.S. and international companies. To qualify for OTCQX, companies must meet high financial standards, follow best practice corporate governance, and demonstrate compliance with applicable securities laws....

Continue reading

Mx2 Mining Completes Transaction with Aya Gold & Silver

TORONTO, April 16, 2025 (GLOBE NEWSWIRE) — Mx2 Mining Inc. (“Mx2” or the “Company”) is pleased to announce the completion of the previously announced transaction with Aya Gold & Silver Inc. (“Aya”), including the acquisition of a 100% interest in the Amizmiz Gold Project (“Amizmiz”) located in the Kingdom of Morocco (the “Transaction”). HIGHLIGHTSMx2 completes its formation, including acquisition of the Amizmiz Gold ProjectHistoric Inferred Mineral Resource: 819,769 tonnes at 12.98 g/t for 342,094 oz (see “Historical Resource” below)Strong shareholder backing following completion of C$16M financingAya subscribed C$1M to the financing and in combination with the Transaction, owns 42.3% Directors and officers own 10.0% Institutional investors own 23.0%Benoit La Salle and Ugo Landry-Tolszczuk have been appointed to...

Continue reading

U.S. Energy Corp. Announces Acreage Acquisition and CCUS Development Update

HOUSTON, April 16, 2025 (GLOBE NEWSWIRE) — U.S. Energy Corporation (NASDAQ: USEG, “U.S. Energy” or the “Company”) today announced the closing of a strategic acquisition (the “Acquisition”) from a privately held company for $0.2 million, strengthening its industrial gas and carbon capture platform in Montana. As part of the Acquisition, U.S. Energy acquired approximately 2,300 net acres with carbon dioxide (CO2) rights that are highly contiguous to its existing position across Montana’s Kevin Dome structure. Additionally, the Acquisition includes an active Class II injection well to sequester CO2 captured from U.S. Energy’s upcoming industrial gas processing facility. The permitted well advances the Company’s carbon capture, utilization, and storage (“CCUS”) initiatives within its industrial gas development platform. The Class II...

Continue reading

Draganfly Establishes Public Safety Advisory Board, Appoints Homeland Security and Law Enforcement Expert Paul Goldenberg as Chair

Industry Veteran Joins Draganfly to Drive Innovation at the Intersection of Public Safety and Technology Tampa, FL, April 16, 2025 (GLOBE NEWSWIRE) — Draganfly Inc. (NASDAQ: DPRO) (CSE: DPRO) (FSE: 3U8) (“Draganfly” or the “Company”), an industry-leading developer of drone solutions and systems, is proud to announce the formation of its Public Safety Advisory Board. This new initiative reinforces Draganfly’s commitment to delivering cutting-edge, mission-critical technologies that support enforcement and public safety agencies worldwide. Renowned global public safety expert and Homeland Security advisor Paul Goldenberg will serve as the inaugural Chair of the Board. With more than 30 years of experience in law enforcement, global security, and national intelligence, Goldenberg brings unparalleled expertise to the role. Recently...

Continue reading

UAB „Atsinaujinančios energetikos investicijos“ publishes audited consolidated and separate annual financial statements for 2024

UAB “Atsinaujinančios energetikos investicijos” (the Company) publishes its audited annual consolidated and separate financial statements for 2024 together with Company’s and Group‘s annual report for 2024 Financial results The Company’s objective is to earn a return for the Company’s investors from investments in renewable energy infrastructure facilities and related assets. The main financial indicators for the period were:As at 31 December 2024, the Company’s total assets were EUR 189,795 thousand, total equity was EUR 100,476 thousand, and total liabilities were EUR 89,319 thousand. As at 31 December 2024, the Company’s investment assets at fair value through profit or loss were EUR 159,902 thousand, which compared to 31 December 2023, decreased by EUR 20,158 thousand or 11.20%. The decline in fair value of the investment portfolio...

Continue reading

IREN capacity increased to 40 EH/s

Expansion to 50 EH/s on track for H1 2025 SYDNEY, April 16, 2025 (GLOBE NEWSWIRE) — IREN Limited (NASDAQ: IREN) (together with its subsidiaries, “IREN”), today provided an update on its Bitcoin mining expansion. “We’re proud to have reached 40 EH/s, marking yet another significant step toward our 50 EH/s target,” said Daniel Roberts, IREN Co-Founder and Co-CEO. “The site team’s rapid expansion of data center capacity at Childress coupled with our best-in-class fleet efficiency and low electricity costs has positioned IREN as one of the largest scale, lowest-cost producers of Bitcoin. We expect to maintain this momentum as we continue to scale mining capacity towards 50 EH/s over the coming months.” IREN has increased its installed self-mining capacity from 37 EH/s to 40 EH/s (15 J/TH efficiency), following the commissioning of...

Continue reading

Form 8.3 – [ADVANCED MEDICAL SOLUTIONS GROUP PLC – 15 04 2025] – (CGAML)

FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORERule 8.3 of the Takeover Code (the “Code”) 1.        KEY INFORMATION(a)   Full name of discloser: CANACCORD GENUITY ASSET MANAGEMENT LIMITED (for Discretionary clients)(b)   Owner or controller of interests and short positions disclosed, if different from 1(a):        The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named. N/A(c)   Name of offeror/offeree in relation to whose relevant securities this form relates:        Use a separate form for each offeror/offeree ADVANCED MEDICAL SOLUTIONS GROUP PLC(d)   If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree: N/A(e)   Date...

Continue reading

Awilco Drilling PLC: De-listing Application sent to Oslo Børs

Reference is made to Awilco Drilling PLC’s (‘Awilco Drilling’ or the ‘Company’) stock exchange releases dated 28 March and 16 April regarding the plan for and power of authority given to the Board to apply for de-listing of the Company from Euronext Growth Oslo. Awilco Drilling has today sent an application for de-listing to Oslo Børs. Once the Company is de-listed, the plan is to call for another extraordinary General Meeting to vote on a proposed Company liquidation. A liquidation process is expected to be completed by year-end 2025 and any remaining funds after all costs are covered will be returned to the shareholders. Aberdeen, 16 April 2025For further information please contact: Eric Jacobs, CEO of Awilco Drilling PLCPhone: +47 9529 2271 Cathrine Haavind, Investor Relations of Awilco Drilling PLCPhone: +47 9342 8464Email: ch@awilcodrilling.com This...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.